Delivery Order 36F79724D0159-15B41825F00000178
Award Date
4/1/25
Potential Completion Date
4/30/25
Potential Value
$20K
Federal Agency
Federal Correctional Complex Terre Haute
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Federal Correctional Complex Terre Haute (a civilian federal agency) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract, valued at $12,540.07, is for the supply of FY25 B1 CURASCRIPT OPSUMIT MEDS APR25, which are specialized medications, primarily focused on treating rare diseases such as pulmonary arterial hypertension. This delivery order is part of a larger $219,108,390 multiple-award...
This is a firm fixed-price delivery order contract awarded by the Federal Correctional Institution Fort Worth, a civilian federal agency, to Actelion Pharmaceuticals US, Inc. for the provision of medications for inmate use. The contract has a ceiling value of $98,411.16 and a completion date of June 30, 2021. The contract was issued under Actelion's Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract with the Department of Veterans Affairs (VA), which has a total value of...
This is a firm fixed-price purchase order issued by the Federal Correctional Complex Butner, a civilian agency, to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, a for-profit small business organization. The contract is for the supply of specialty pharmaceutical medications, including Adempas, Opsumit, and Oxbryta, to support patient care programs for federal inmates. The contract has a ceiling value of $165,828.24 and a completion date of July...
This federal contract award, valued at $72,516.33, was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc., a large for-profit pharmaceutical manufacturer. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs (VA), which has a total potential value of $219,108,390 over the period of August 2024 to July 2029.
The contract provides...
The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $36,202.48 firm fixed price delivery order contract to Actelion Pharmaceuticals US, Inc. for the provision of 30-count bottles of the pharmaceutical CURASCRIPT, OPSUMIT 10MG to treat pulmonary arterial hypertension. Actelion will deliver the medication under the Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract, identified as Schedule 61-IB. Performance will occur...
This federal contract award was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc. The $72,226.86 fixed-price delivery order is for the procurement of various medications used to treat pulmonary arterial hypertension, including Opsumit, Uptravi, and Adempas. The contract does not utilize a small business set-aside.
Actelion Pharmaceuticals US, Inc. is a for-profit pharmaceutical manufacturer that specializes in...
This is a delivery order contract awarded to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, to provide 1600 mcg, 60-count bottles of the drug Uptravi to the Department of Justice Bureau of Prisons Federal Medical Center Carswell. The contract is set against Actelion's $105 million Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, as well as a separate $60 million Blanket Purchase Agreement focused on pulmonary arterial...
This is a delivery order awarded by the Federal Medical Center Carswell, a civilian agency, to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The $1,349.96 firm-fixed-price contract is for the supply of Ambrisentan 10mg 30-count bottles, a medication used to treat pulmonary arterial hypertension.
The contract was awarded under Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Actelion also holds a $60...
This is a federal contract award to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer, to provide Uptravi (selexipag) and other pulmonary arterial hypertension treatments to the Department of Veterans Affairs (VA) and Federal Bureau of Prisons. The contract, valued at $412,749.22, was awarded on October 1, 2024 and will run through September 30, 2025. This order was placed against Actelion's existing Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceuticals and specialty drug therapies. The $132,282.00 delivery order is funded through the VA's Veterans Integrated Service Network 12 and provides Actelion's pulmonary arterial hypertension medications, including Opsumit, Uptravi, Tracleer, and Ventavis, to VA healthcare facilities and federal...